ATAI Life Sciences NV (ATAI)
2.12
+0.07
(+3.41%)
USD |
NASDAQ |
May 02, 16:00
2.13
+0.01
(+0.47%)
Pre-Market: 08:10
ATAI Life Sciences Net Income (Quarterly): -18.29M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.29M |
| September 30, 2023 | 44.24M |
| June 30, 2023 | -33.04M |
| March 31, 2023 | -33.14M |
| December 31, 2022 | -45.01M |
| September 30, 2022 | -33.89M |
| June 30, 2022 | -36.62M |
| March 31, 2022 | -36.87M |
| Date | Value |
|---|---|
| December 31, 2021 | -88.88M |
| September 30, 2021 | -31.16M |
| June 30, 2021 | -48.46M |
| March 31, 2021 | 0.688M |
| December 31, 2020 | -86.59M |
| September 30, 2020 | -83.20M |
| June 30, 2020 | -16.36M |
| March 31, 2020 | 16.30M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-88.88M
Minimum
Dec 2021
44.24M
Maximum
Sep 2023
-33.14M
Average
-33.51M
Median
Net Income (Quarterly) Benchmarks
| Affimed NV | -21.76M |
| InflaRx NV | -17.16M |
| MorphoSys AG | 51.98M |
| BioNTech SE | 493.12M |
| Immatics NV | -28.16M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.018M |
| Total Expenses (Quarterly) | 31.13M |
| EPS Diluted (Quarterly) | -0.11 |
| Enterprise Value | 191.95M |
| Profit Margin (Quarterly) | -101.6K% |
| Earnings Yield | -13.21% |
| Normalized Earnings Yield | -35.26 |